말초혈관 디바이스 시장 규모, 점유율과 동향 분석 리포트 : 유형별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Peripheral Vascular Devices Market Summary

The global peripheral vascular devices market size was estimated at USD 10.44 billion in 2024 and is projected to reach USD 16.90 billion by 2033, growing at a CAGR of 5.3% from 2025 to 2033. The rising prevalence of peripheral arterial disease (PAD) is significantly driving the growth of the peripheral vascular devices market.

PAD has a significantly high prevalence in both developed and emerging economies globally. For instance, according to a study published in the American Heart Association Journals in June 2023, more than 12 million Americans had PAD, with global prevalence reaching around 200 million people. Similarly, according to the Australian Institute of Health and Welfare data article published in June 2024, PAD was recorded in around 59,100 hospitalizations in 2020-21.

The growth of the peripheral vascular devices market is significantly influenced by the increasing number of clinical trials and studies focusing on vascular health. Clinical trials allow researchers to evaluate the safety and efficacy of new devices and techniques in treating peripheral vascular diseases (PVD). For instance, in March 2024, BD started the AGILITY study by enrolling its first patient to assess the safety and efficacy of the BD Vascular Covered Stent for the treatment of PAD. Three hundred fifteen patients likely to participate in this international, multi-center clinical trial at 40 locations in the U.S., Europe, Australia, and New Zealand. The study aims to address critical unmet needs in the treatment of PAD. These trials validate current technologies and give way to new treatments that meet unmet medical needs as they grow.

Introducing novel products that address the evolving needs of patients and healthcare providers significantly contributes to market growth. The launch of these products includes cutting-edge technologies such as drug-eluting capabilities, bioresorbable materials, and others. For instance, in December 2023, Terumo India launched Ultimaster Nagomi, an advanced drug-eluting coronary stent system designed for complex percutaneous coronary interventions (PCI). The stent features an optimized delivery system, expanded size range, and increased overexpansion capability, allowing it to adapt to challenging anatomies. Ultimate Nagomi aims to improve patient outcomes by enabling customized stent selection for small to large coronary arteries.

Moreover, in May 2024, Abbott introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, designed to enhance treatment for patients with blocked coronary arteries. This next-generation stent features an improved design, a new delivery system, and specialized sizes to address complex cases effectively. XIENCE Sierra aims to provide greater flexibility and precision for interventional cardiologists, making it easier to navigate challenging blockages. This focus on innovation addresses clinical challenges and enhances procedural efficiency, leading to increased adoption of these devices among healthcare professionals.

Global Peripheral Vascular Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global peripheral vascular devices market report based on type, application, end use, and region:

• Type Outlook (Revenue USD Million, 2021 - 2033)
• Peripheral Stents
  • Iliac Artery Stents
  • Femoral Artery Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Other Peripheral Stents
• PTA Balloons
• Catheters
  • Angiography Catheters
  • Guiding Catheters
  • IVUS/OCT Catheters
• Endovascular Aneurysm Repair Stent Grafts
  • Thoracic Endovascular Aneurysm Stent Grafts
  • Abdominal Endovascular Aneurysm Stent Grafts
• Plaque Modification Devices
  • Atherectomy Devices
  • Thrombectomy Devices
• Peripheral Accessories
  • Guidewires
  • Workhorse Guidewires
  • Specialty Guidewires
  • Extra Support Guidewires
  • Frontline Finesse Guidewires
  • Peripheral Vascular Closure Devices
  • Balloon Inflation Devices
  • Introducer Sheaths
• Inferior Vena Cava Filters
  • Permanent Filters
  • Retrievable Filters
• Hemodynamic Flow Alteration Devices
  • Chronic Total Occlusion Devices
  • Embolic Protection Devices
• Application Outlook (Revenue USD Million, 2021 - 2033)
• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases
• Others
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. Global Peripheral Vascular Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Global Peripheral Vascular Devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis
• 3.6. Peripheral Vascular Devices: Industry Trend Analysis
• 3.7. Regulatory Scenario
• 3.8. Key Customers

Chapter 4. Global Peripheral Vascular Devices Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Peripheral Vascular Devices Market, by Type, 2021 to 2033
• 4.5. Peripheral Stents
  • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.1.1. Iliac Artery Stents
      • 4.5.1.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.1.2. Femoral Artery Stents
      • 4.5.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.1.3. Carotid Artery Stents
      • 4.5.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.1.4. Renal Artery Stents
      • 4.5.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.1.5. Other Peripheral Stents
      • 4.5.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. PTA Balloons
  • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Catheters
  • 4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.7.1.1. Angiography Catheters
      • 4.7.1.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.7.1.2. Guiding Catheters
      • 4.7.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.7.1.3. IVUS/OCT Catheters
      • 4.7.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.8. Endovascular Aneurysm Repair Stent Grafts
  • 4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.8.1.1. Thoracic Endovascular Aneurysm Stent Grafts
      • 4.8.1.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.8.1.2. Abdominal Endovascular Aneurysm Stent Grafts
      • 4.8.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.9. Plaque Modification Devices
  • 4.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.9.1.1. Atherectomy Devices
      • 4.9.1.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.9.1.2. Thrombectomy Devices
      • 4.9.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.10. Peripheral Accessories
  • 4.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.10.1.1. Guidewires
      • 4.10.1.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.10.1.1.2. Workhorse Guidewires
        • 4.10.1.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.10.1.1.3. Specialty Guidewires
        • 4.10.1.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.10.1.1.4. Extra Support Guidewires
        • 4.10.1.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.10.1.1.5. Frontline Finesse Guidewires
        • 4.10.1.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.10.1.2. Peripheral Vascular Closure Devices
      • 4.10.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.10.1.3. Balloon Inflation Devices
      • 4.10.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.10.1.4. Introducer Sheaths
      • 4.10.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.11. Inferior Vena Cava Filters
  • 4.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.11.2. Permanent Filters
    • 4.11.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.11.3. Retrievable Filters
    • 4.11.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 4.12. Hemodynamic Flow Alteration Devices
  • 4.12.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.12.2. Chronic Total Occlusion Devices
    • 4.12.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.12.3. Embolic Protection Devices
    • 4.12.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Peripheral Vascular Devices Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Peripheral Vascular Devices Market, by Application, 2021 to 2033
• 5.5. Peripheral Arterial Disease (PAD)
  • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Aneurysms
  • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Venous Diseases
  • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Peripheral Vascular Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Peripheral Vascular Devices Market, by End Use, 2021 to 2033
• 6.5. Hospitals
  • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Peripheral Vascular Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Peripheral Vascular Devices Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico peripheral vascular devices market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark peripheral vascular devices market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand peripheral vascular devices market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina peripheral vascular devices market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE peripheral vascular devices market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait peripheral vascular devices market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Abbott
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Koninklijke Philips N.V.
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Edward Lifesciences Corporation
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medtronic
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Teleflex Incorporated
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Cook
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Cordis (Hellman & Friedman (H&F))
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Boston Scientific Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. W. L. Gore & Associates, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Biotronik
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. BD
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Terumo Corporation
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives